Brandon Capital’s $60m taypayer-funded biotech bets
Around $60 million in taxpayer funds has been deployed by Brandon Capital to startups working on cancer cures, infection prevention, fibrosis treatment and more. Brandon Capital has deployed around $60 million of National Reconstruction Fund capital across 10 biotech startups over the past year, championing the NRF as helping to keep promising technology in the […]